Prevalence and Predictors of Neurocognitive Impairment Among HIV-infected Patients

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-04-30

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite the advent of highly active antiretroviral therapy (HAART), the prevalence of neurocognitive impairment among HIV-infected patients continues to be an important issue. Although severe forms of AIDS-related dementia have diminished, milder forms of cognitive impairment have been noted among approximately 30% of asymptomatic HIV patients. Studies among HIV-infected U.S. military personnel regarding neurocognitive function have largely been limited to the early 1990s, before the advent of HAART. In these studies subtle neurobehavioral changes were noted among asymptomatic HIV-positive military personnel.

This study proposes to determine the prevalence of neurocognitive deficits among HIV-positive military beneficiaries during the era of HAART who are participants of the U.S. Military HIV Natural History Study. The prevalence ascertained in this study will be compared to HIV-negative military beneficiaries who are demographically similar to the HIV positive group. The sample size of the study is to have complete testing on 200 HIV positive and 50 HIV-negative participants; due to the possibility of attrition before study completion, the investigators will enroll up to 300 participants (240 HIV-positive and 60 HIV-negative) to achieve this sample size. The investigators' rates among HIV-positive patients found in this study will also be contextualized in the setting of the prevalence of prior neurocognitive deficits seen in a HIV positive U.S. military population studied in the 1990s, contemporary rates among civilian HIV-infected persons, and normative values in the general HIV-negative population. Compared to other data in the field of neuropsychology, this study is novel in that the HIV population studied is composed largely of HIV patients who have been diagnosed early in their HIV infection; have open, free access to antiretrovirals to begin therapy earlier than most other cohorts; and consists of highly-functioning, educated individuals.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Thinking and Memory Problems in People With HIV

NCT01875588

HIV Positive

RECRUITING

Observational Study of HIV-associated Neurocognitive Disorder

NCT01966094

HIV Associated Neurocognitive Disorder Human Immunodeficiency Virus

COMPLETED

Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1

NCT00476671

HIV Infections

COMPLETED

COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old

NCT03268109

Memory Impairment HIV/AIDS Cognitive Impairment

COMPLETED

Prevalence of HIV-associated Neurocognitive Disorders (HAND) in a School of Medicine HIV/AIDS Outpatient Clinic

NCT02187796

HIV-ASSOCIATED NEUROCOGNITIVE DISORDER (HAND)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Abbreviations:

DOD - U.S. Department of Defense; CD4 - cluster of differentiation 4

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections Memory

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

HIV-Positive and Early HIV infection (\<6 years of HIV infection since diagnosis \[based on DoD standard testing\], no prior AIDS-defining condition, and CD4 nadir \>200 cells/mm3)

No interventions assigned to this group

2

HIV-Positive and Late HIV-infection (HIV infected, not meeting all 3 criteria)

No interventions assigned to this group

3

HIV-negative (HIV uninfected based on DoD standard testing)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* HIV-infected patients who are 18-50 years of age
* Current participants in the U.S. Military HIV Natural History Study (RV168)

* Between 18 and 50 years of age.
* A military beneficiary
* HIV negative by an ELISA drawn within one year of study enrollment (or willingness to have HIV test performed which has a negative result)

Exclusion Criteria

* Current suicidal ideation
* Inability or unwillingness to complete the full or abbreviated neuropsychological battery and other questionnaires
* An acute medical condition that may impact the participant's ability to complete the tests or that may have a significant impact on the test results as deemed by the site research physicians (e.g., pneumonia, influenza); the subject may participate at a later date if the physician deems that the acute medical illness is resolved.

HIV Negative Group:

* Inability or unwillingness to complete the full or abbreviated neuropsychological battery and other questionnaires
* Presence of current suicidal thoughts
* An acute medical condition that may impact the participant's ability to complete the tests or that may have a significant impact on the test results as deemed by the site research physicians (e.g., pneumonia, influenza); the subject may participate at a later date if the physician deems that the acute medical illness is resolved.

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes